Influence of isothermal treatment on MnS and hot ductility in low carbon, low Mn steels

Hot ductility tests were used to determine the hot-cracking susceptibility of two low-carbon, low Mn/S ratio steels and compared with a higher-carbon plain C-Mn steel and a low C, high Mn/S ratio steel. Specimens were solution treated at 1623 K (1350 °C) or in situ melted before cooling at 100 K/min to various testing temperatures and strained at 7.5 x 10-4 s -1, using a Gleeble 3500 Thermomechanical Simulator. The low C, low Mn/S steels showed embrittlement from 1073 K to 1323 K (800 °C to 1050 °C) because of precipitation of MnS at the austenite grain boundaries combined with large grain size. Isothermal holding for 10 minutes at 1273 K (1000 °C) coarsened the MnS leading to significant improvement in hot ductility. The highercarbon plain C-Mn steel only displayed a narrow trough less than the Ae3 temperature because of intergranular failure occurring along thin films of ferrite at prior austenite boundaries. The low C, high Mn/S steel had improved ductility for solution treatment conditions over that of in situ melt conditions because of the grain-refining influence of Ti. The higher Mn/S ratio steel yielded significantly better ductility than the low Mn/S ratio steels. The low hot ductility of the two low Mn/S grades was in disagreement with commercial findings where no cracking susceptibility has been reported. This discrepancy was due to the oversimplification of the thermal history of the hot ductility testing in comparison with commercial production leading to a marked difference in precipitation behavior, whereas laboratory conditions promoted fine sulfide precipitation along the austenite grain boundaries and hence, low ductility

Effect of microstructural morphology on the mechanical properties of titanium alloys

Different morphologies of α+β microstructures were obtained in a commercial Ti-6Al-4V alloy by cooling at different rates from the single β-phase region into the two phase region. The effect of such morphologies on mechanical properties was studied using hot compression tests in a Gleeble thermomechanical simulator. A variety of complex morphologies could be obtained since the cooling rate has a significant influence on the β to α phase transformation and the resulting morphological development. While most of the β phase transformed to colonies of α at high cooling rates, it was possible to obtain a complex mixture of a colonies, grain boundary a and lamellar structure by decreasing the cooling rate. These complex morphologies each exhibited distinctive mechanical properties and characteristic dynamic phase transformation behaviour during deformation as a function of strain rate

Cretaceous fossils from the Orapa Diamond Mine

Main articleThe Orapa kimberlite pipe, situated in north-central Botswana, is well-known for its rich reserves of diamonds. It is indeed one of the largest and richest diamond mines in the world. The kimberlite magma transporting the diamonds from the upper mantle erupted through a sequence ofKaroo-aged rocks before the deposition ofthe Kalahari Sands. This eruption has been radiometrically dated at early Late Cretaceous (Cenomanian-Coniacian). When volcanism ceased, a succession of epiclastic crater lake sediments was deposited above the kimberlite plug. Analysis of these sediments, which mostly comprise the results of mudflows and debris flows and fmer sediments during quiescenttimes, suggests that most of the sediments within the crater were deposited rapidly as mass flows, and were therefore mobilised soon after the volcanic eruption. Buried within the fine-grained sediments is a unique assemblage of fossils including flowering plants and many whole-bodied insects. The fossils are commonly exquisitely preserved in extremely fine-grained mudstone. Interpretation of the sedimentary facies and fossils is that the mid-Cretaceous climate of central Botswana was temperate, seasonal and wet, and the area surrounding the crater was forested. The fossils represent the recovery of the biota of the area after the violent eruptions of Orapa and other nearby kimberlite fissures and pipes. The fossils have contributed considerably to our understanding of mid-Cretaceous insects and flowering plants and suggest intimate relationships between the two at an early stage in the radiation of flowering plants. It seems that southern Gondwana (including southern Africa) was a centre of diversification for both insects and angiosperms in the mid-Cretaceous.Friends of the Museum, Gaborone; Debswana (Orapa); University of the Witwatersrand; South African Foundation for Research Developmen

An epidemiological study of a patient population, triage category allocations and principal diagnosis within the emergency centres of a private healthcare group in the Emirate of Dubai, United Arab Emirates

Aim: To describe, compare and correlate the number of patients seen, their demographics, triage category allocations and principal diagnosis in four emergency centres; to better understand the patient population and triage practices in this setting. Design: An observational, cross-sectional, epidemiological study. Methods: Electronic medical records were retrospectively evaluated from patients triaged in each of the four emergency centres over six months. Descriptive statistics were used to describe the patient demographics and variance between triage category allocations. Results: A total of 56,984 patient records were captured, with an equal gender split and the workforce being the largest patient population (20–50 years). Acute upper respiratory infection was the most prolific diagnosis, and lower acuity triage categories were allocated the most. There were inconsistencies in the application of triage systems between the emergency centres, the most obvious being the variance in triage system selection and application

A review of the use of blood and blood products in HIV-infected patients

Despite numerous publications on the appropriate use of blood and blood products, few specifically consider the role of transfusion in the management of HIV. This review is a synthesis of conditions encountered in the management of HIV-infected patients where the transfusion of blood or blood products may be indicated. A consistent message emerging from the review is that the principles of transfusion medicine do not differ between HIV-negative and -positive patients. The aim of the review is to provide clinicians witha practical and succinct overview of the haematological abnormalities and clinical circumstances most commonly encountered in the HIV setting, while focusing on the rational and appropriate use of blood and blood products forHIV patients. Important ethical considerations in dealing with both the collection and transfusion blood and blood products in the HIV era have also been addressed

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

Background: South Africa has a high burden of rifampicin-resistant tuberculosis (including multidrug-resistant [MDR] tuberculosis), with increasing rifampicin-monoresistant (RMR) tuberculosis over time. Resistance acquisition during first-line tuberculosis treatment could be a key contributor to this burden, and HIV might increase the risk of acquiring rifampicin resistance. We assessed whether HIV during previous treatment was associated with RMR tuberculosis and resistance acquisition among a retrospective cohort of patients with MDR or rifampicin-resistant tuberculosis. Methods: In this retrospective cohort study, we included all patients routinely diagnosed with MDR or rifampicin-resistant tuberculosis in Khayelitsha, Cape Town, South Africa, between Jan 1, 2008, and Dec 31, 2017. Patient-level data were obtained from a prospective database, complemented by data on previous tuberculosis treatment and HIV from a provincial health data exchange. Stored MDR or rifampicin-resistant tuberculosis isolates from patients underwent whole-genome sequencing (WGS). WGS data were used to infer resistance acquisition versus transmission, by identifying genomically unique isolates (single nucleotide polymorphism threshold of five). Logistic regression analyses were used to assess factors associated with RMR tuberculosis and genomic uniqueness. Findings: The cohort included 2041 patients diagnosed with MDR or rifampicin-resistant tuberculosis between Jan 1, 2008, and Dec 31, 2017; of those, 463 (22.7%) with RMR tuberculosis and 1354 (66.3%) with previous tuberculosis treatment. In previously treated patients, HIV positivity during previous tuberculosis treatment versus HIV negativity (adjusted odds ratio [OR] 2.07, 95% CI 1.35-3.18), and three or more previous tuberculosis treatment episodes versus one (1.96, 1.21-3.17) were associated with RMR tuberculosis. WGS data showing MDR or rifampicin-resistant tuberculosis were available for 1169 patients; 360 (30.8%) isolates were identified as unique. In previously treated patients, RMR tuberculosis versus MDR tuberculosis (adjusted OR 4.96, 3.40-7.23), HIV positivity during previous tuberculosis treatment (1.71, 1.03-2.84), and diagnosis in 2013-17 (1.42, 1.02-1.99) versus 2008-12, were associated with uniqueness. In previously treated patients with RMR tuberculosis, HIV positivity during previous treatment (adjusted OR 5.13, 1.61-16.32) was associated with uniqueness as was female sex (2.50 [1.18-5.26]). Interpretation: These data suggest that HIV contributes to rifampicin-resistance acquisition during first-line tuberculosis treatment and that this might be driving increasing RMR tuberculosis over time. Large-scale prospective cohort studies are required to further quantify this risk. Funding: Swiss National Science Foundation, South African National Research Foundation, and Wellcome Trust

Rifampicin mono-resistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa

Rifampicin mono-resistant TB (RMR-TB, rifampicin resistance and isoniazid susceptibility) constitutes 38% of all rifampicin-resistant TB (RR-TB) in South Africa and is increasing. We aimed to compare RMR-TB with multidrug-resistant TB (MDR-TB) within a high TB, RR-TB and HIV burden setting. Patient-level clinical data and stored RR-TB isolates from 2008-2017 with available whole genome sequencing (WGS) data were used to describe risk factors associated with RMR-TB and to compare rifampicin-resistance (RR) conferring mutations between RMR-TB and MDR-TB. A subset of isolates with particular RR-conferring mutations were subjected to semi-quantitative rifampicin phenotypic drug susceptibility testing. Among 2,041 routinely diagnosed RR-TB patients, 463 (22.7%) had RMR-TB. HIV-positive individuals (adjusted Odds Ratio 1.4, 95% CI 1.1-1.9) and diagnosis between 2013-2017 versus 2008-2012 (aOR 1.3, 1.1-1.7) were associated with RMR-TB. Among 1,119 (54.8%) patients with available WGS data showing RR-TB, significant differences in the distribution of rpoB RR-conferring mutations between RMR-TB and MDR-TB isolates were observed. Mutations associated with high-level RR were more commonly found among MDR-TB isolates (811/889, 90.2% versus 162/230, 70.4% among RMR-TB, p<0.0001). In particular, the rpoB L430P mutation, conferring low-level RR, was identified in 32/230 (13.9%) RMR-TB versus 10/889 (1.1%) in MDR-TB (p<0.0001). Among 10 isolates with an rpoB L430P mutation, 7 were phenotypically susceptible using the critical concentration of 0.5 mug/ml (range 0.125-1 mug/ml). The majority (215/230, 93.5%) of RMR-TB isolates showed susceptibility to all other TB drugs, highlighting the potential benefits of WGS for simplified treatment. These data suggest that the evolution of RMR-TB differs from MDR-TB with a potential contribution from HIV infection